SCHEMBL2288235

SCHEMBL2288235

C#CC[S+](CC[C@H](N)C(=O)O)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 5/20 0.74
AMD1 P17707 2/20 0.74
NNMT P40261 4/20 0.68
TRDMT1 O14717 4/20 0.67
DOT1L Q8TEK3 5/20 0.66
PCMT1 P22061 3/20 0.66
NSD2 O96028 3/20 0.66
SETD7 Q8WTS6 3/20 0.66
PRMT5 O14744 3/20 0.66
PRMT1 Q99873 3/20 0.66
EHMT2 Q96KQ7 3/20 0.66
NSD3 Q9BZ95 2/20 0.66
INMT O95050 2/20 0.66
METTL3 Q86U44 2/20 0.66
EHMT1 Q9H9B1 2/20 0.66
METTL14 Q9HCE5 2/20 0.66
RNMT O43148 1/20 0.66
TPMT P51580 1/20 0.66
NSD1 Q96L73 1/20 0.66
SETD2 Q9BYW2 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2288255 1.00 CARM1 (0.74) CARM1AMD1NNMTTRDMT1DOT1L
SCHEMBL2288248 1.00 CARM1 (0.74) CARM1AMD1NNMTTRDMT1DOT1L
SCHEMBL2292558 0.90 CARM1 (0.75) CARM1AMD1NNMTTRDMT1DOT1L
SCHEMBL2292568 0.90 CARM1 (0.75) CARM1AMD1NNMTTRDMT1DOT1L
SCHEMBL2292552 0.90 CARM1 (0.75) CARM1AMD1NNMTTRDMT1DOT1L
SCHEMBL12378926 0.90 CARM1 (0.75) CARM1AMD1NNMTTRDMT1DOT1L
SCHEMBL2284468 0.90 CARM1 (0.73) CARM1AMD1NNMTTRDMT1DOT1L
SCHEMBL2284459 0.90 CARM1 (0.73) CARM1AMD1NNMTTRDMT1DOT1L
SCHEMBL2284452 0.90 CARM1 (0.73) CARM1AMD1NNMTTRDMT1DOT1L
SCHEMBL2287096 0.89 CARM1 (0.81) CARM1AMD1NNMTTRDMT1DOT1L

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008007-B2 S-adenosyl-L-methionine analogs with extended activated groups for transfer by methyltransferases RWTH AACHEN (DE) 2011-08-30 US disclosed
EP-1874790-B1 NEW S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES RWTH AACHEN (DE) 2010-08-18 EP disclosed
US-20090018101-A1 S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES RWTH AACHEN (DE) 2009-01-15 US disclosed
EP-1874790-A2 NEW S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES RWTH Aachen (DE) 2008-01-09 EP disclosed
WO-2006108678-A2 NEW S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES RWTH AACHEN (DE) 2006-10-19 WO disclosed
EP-1712557-A1 New s-adenosyl-L-methionine analogues with extended activated groups for transfer by methyltransferases RWTH Aachen (DE) 2006-10-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018101-A1 S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES BHMT2, MSRB3, PRMT3 CARM1 35/4885AMD1 20/4885NNMT 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.